Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Mechanistic Models: Compartment Models in Algorithms for Numerical Problem Solving01:29

Mechanistic Models: Compartment Models in Algorithms for Numerical Problem Solving

48
Mechanistic models play a crucial role in algorithms for numerical problem-solving, particularly in nonlinear mixed effects modeling (NMEM). These models aim to minimize specific objective functions by evaluating various parameter estimates, leading to the development of systematic algorithms. In some cases, linearization techniques approximate the model using linear equations.
In individual population analyses, different algorithms are employed, such as Cauchy's method, which uses a...
48
Model Approaches for Pharmacokinetic Data: Compartment Models01:14

Model Approaches for Pharmacokinetic Data: Compartment Models

88
Compartmental analysis is a widely adopted approach to characterizing drug pharmacokinetics. It uses compartment models that conceptualize the body as a collection of reversibly communicating compartments, each representing a group of tissues exhibiting similar drug distribution characteristics. The movement rate of the drug between these compartments is typically described by first-order kinetics.
Two primary types of compartment models are recognized: mammillary and catenary. The more...
88
Compartment Models: Single-Compartment Model01:14

Compartment Models: Single-Compartment Model

2.2K
The single-compartment model serves as a simplified representation of the human body. This model assumes that the body functions as a single, well-mixed open compartment. When a drug is administered intravenously, it enters the body and quickly distributes uniformly. The drug then undergoes biotransformation and elimination, ultimately leaving the body. The volume of this compartment is referred to as the apparent volume of distribution into which the drug can uniformly distribute. In this...
2.2K
Multicompartment Models: Overview01:14

Multicompartment Models: Overview

123
Multicompartment models are mathematical constructs that depict how drugs are distributed and eliminated within the body. They segment the body into several compartments, symbolizing various physiological or anatomical areas connected through drug transfer processes such as absorption, metabolism, distribution, and elimination.
These models offer a more comprehensive representation of drug behavior in the body than one-compartment models. They accommodate the complexity of drug distribution,...
123
Mechanistic Models: Compartment Models in Individual and Population Analysis01:23

Mechanistic Models: Compartment Models in Individual and Population Analysis

36
Mechanistic models are utilized in individual analysis using single-source data, but imperfections arise due to data collection errors, preventing perfect prediction of observed data. The mathematical equation involves known values (Xi), observed concentrations (Ci), measurement errors (εi), model parameters (ϕj), and the related function (ƒi) for i number of values. Different least-squares metrics quantify differences between predicted and observed values. The ordinary least...
36
Compartment Models: Two-Compartment Model01:20

Compartment Models: Two-Compartment Model

5.4K
The two-compartment model divides the body into central and peripheral compartments to account for varying blood perfusion rates among organs and tissues, affecting drug distribution. The central compartment includes blood and highly perfused tissues with rapid drug distribution, while the peripheral compartment contains tissues with slower drug distribution. After a single IV bolus dose, the drug concentration is high in plasma and low in tissues. The drug distribution between compartments...
5.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Undetectable Hydroxyurea Levels in the Majority of Sickle Cell Disease Patients, Especially in Young Children.

American journal of hematology·2026
Same author

Reagent-specific anti-Xa DOAC safety cutoffs can be established using multiple LMWH-calibrated anti-Xa assays.

Clinical chemistry and laboratory medicine·2026
Same author

Pediatric pharmacokinetics and pharmacodynamics of guanabenz for the treatment of vanishing white matter.

Scientific reports·2026
Same author

Psychometric evaluation of Patient-Reported Outcomes Measurement Information System (PROMIS) in pediatric sickle cell disease in Europe.

European journal of pediatrics·2026
Same author

Advancing Precision Dosing of 5-FU: Population PK Model Development, Limited Sampling Strategies, and Fit-for-Use Application.

Clinical pharmacokinetics·2026
Same author

Three-year safety, efficacy, and renal outcomes of mitapivat treatment in sickle cell disease: results from the phase 2 open-label study.

Haematologica·2026

Related Experiment Video

Updated: Jun 22, 2025

Development of an Individual-Tree Basal Area Increment Model using a Linear Mixed-Effects Approach
04:35

Development of an Individual-Tree Basal Area Increment Model using a Linear Mixed-Effects Approach

Published on: July 3, 2020

3.3K

Mixed effect estimation in deep compartment models: Variational methods outperform first-order approximations.

Alexander Janssen1, Frank C Bennis2, Marjon H Cnossen3

  • 1Department of Clinical Pharmacology, Hospital Pharmacy, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands. a.janssen@amsterdamumc.nl.

Journal of Pharmacokinetics and Pharmacodynamics
|July 4, 2024
PubMed
Summary
This summary is machine-generated.

This study introduces mixed-effects estimation into the deep compartment model (DCM) framework. Variational inference (VI) demonstrated accurate and stable predictions for personalized drug dosing, outperforming traditional methods.

Keywords:
Estimation methodsMachine LearningPharmacokineticsPharmacometricsVariational Inference

More Related Videos

Basics of Multivariate Analysis in Neuroimaging Data
06:35

Basics of Multivariate Analysis in Neuroimaging Data

Published on: July 24, 2010

16.8K
A Psychophysics Paradigm for the Collection and Analysis of Similarity Judgments
08:12

A Psychophysics Paradigm for the Collection and Analysis of Similarity Judgments

Published on: March 1, 2022

2.5K

Related Experiment Videos

Last Updated: Jun 22, 2025

Development of an Individual-Tree Basal Area Increment Model using a Linear Mixed-Effects Approach
04:35

Development of an Individual-Tree Basal Area Increment Model using a Linear Mixed-Effects Approach

Published on: July 3, 2020

3.3K
Basics of Multivariate Analysis in Neuroimaging Data
06:35

Basics of Multivariate Analysis in Neuroimaging Data

Published on: July 24, 2010

16.8K
A Psychophysics Paradigm for the Collection and Analysis of Similarity Judgments
08:12

A Psychophysics Paradigm for the Collection and Analysis of Similarity Judgments

Published on: March 1, 2022

2.5K

Area of Science:

  • Pharmacometrics
  • Computational Biology
  • Statistical Modeling

Background:

  • The deep compartment model (DCM) is a powerful tool for pharmacokinetic/pharmacodynamic (PK/PD) analysis.
  • Estimating mixed-effects in DCMs is crucial for personalized medicine and optimizing treatment strategies.
  • Existing methods for mixed-effects estimation in DCMs have limitations in accuracy and stability.

Purpose of the Study:

  • To extend the deep compartment model (DCM) framework for mixed-effects estimation.
  • To compare the performance of first-order (FO, FOCE) and variational inference (VI) algorithms for mixed-effects estimation in DCMs.
  • To evaluate the accuracy and stability of these methods using simulated and real-world data.

Main Methods:

  • Implementation of mixed-effects estimation within the DCM framework.
  • Comparison of first-order conditional estimation (FOCE), first-order (FO), and variational inference (VI) algorithms.
  • Validation using simulated datasets and real-world data from Haemophilia A patients.

Main Results:

  • Variational inference (VI) using path derivative gradient estimators showed high accuracy in approximating posterior distributions.
  • Both FO and VI methods yielded accurate population parameters and covariate effects in simulations, while FOCE showed instability and inaccurate estimates.
  • FO and VI methods produced similar results on real-world Haemophilia A data, with some FO models showing divergence; FOCE remained unstable.

Conclusions:

  • Mixed-effects estimation using the deep compartment model (DCM) is feasible and effective.
  • Variational inference (VI) offers a stable and accurate alternative for mixed-effects estimation in DCMs, potentially outperforming first-order (FO) methods in complex models.
  • The findings support the use of VI for personalized treatment optimization in pharmacometric modeling.